Your search returned 199 results.

Sort
Results
Isotonitazene : initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl] methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Initial reportsLanguage: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
COVID-19 and drugs : drug supply via darknet markets [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Impact of COVID-19 on drug services and help-seeking in Europe : EMCDDA trendspotter briefing [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Impact of COVID-19 on patterns of drug use and drugrelated harms in Europe [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
ESPAD report 2019 : results from the European School Survey Project on Alcohol and Other Drugs [PDF] by
  • ESPAD Group
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Isotonitazene Report on the risk assessment of N,N-diethyl-2- [[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole-1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
Series: Risk assessments ; 31Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dime- thylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Risk assessment report on a new psychoactive substance: methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2020
Availability: Items available for reference: VAD: Not for loan (1).
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Series: Technical reportLanguage: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
New benzodiazepines in Europe : a review [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2021
Availability: Items available for reference: VAD: Not for loan (1).
Synthetic cannabinoids in Europe : a review [PDF] Series: Technical reportLanguage: Engels
Publication details: Lisbon European Monitoring Centre for Drugs and Drug Addiction [EMCDDA] 2021
Availability: Items available for reference: VAD: Not for loan (1).
New psychoactive substances: 25 years of early warning and response in Europe [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]
Language: Engels
Publication details: Lisbon EMCDDA 2022
Availability: Items available for reference: VAD: Not for loan (1).
European Web Survey on Drugs 2021: top level findings, 21 EU countries and Switzerland [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Language: Engels
Publication details: Lisbon EMCDDA 2022
Availability: Items available for reference: VAD: Not for loan (1).
EU Drug Market: Cocaine: In-depth analysis [PDF] by
  • EMCDDA
  • Europol
Language: Engels
Publication details: Lisbon EMCDDA 2022
Availability: Items available for reference: VAD: Not for loan (1).
Drug-related health and security threats in the Western Balkans : Regional report [PDF] by
  • Cunningham, Andrew
  • Denecker, Fréderic
  • Griffiths, Paul
  • Mounteny, Jane
  • Noor, André
  • Patrancus, Robert
  • Sedefov, Roumen
  • Skarupova, Katerina
  • Soderholm; Alexander
Language: Engels
Publication details: Luxembourg EMCDDA 2022
Availability: Items available for reference: VAD: Not for loan (1).
EU Early Warning System on NPS — 25 years [PDF] by
  • Planchuelo, Gregorio
  • Gallegos, Ana
  • Evans-Brown, Michael
  • Christie, Rachel
  • Jorge, Rita
  • De Morais, Joanna
  • Sedefov, Roumen
Language: Engels
Publication details: Luxemburg EMCDDA 2022
Availability: Items available for reference: VAD: Not for loan (1).
European Drug Report 2023: Trends and Developments [PDF] by
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Language: Engels
Publication details: Lissabon EMCDDA 2023
Availability: Items available for reference: VAD: Not for loan (1).
Pages